These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 382979

  • 1. Controversy in neurology: the Canadian study on TIA and aspirin. A critique of the Canadian TIA study. Reply.
    Barnett HJ, Gent M, Sackett DL, Taylor DW.
    Ann Neurol; 1979 Jun; 5(6):599-601. PubMed ID: 382979
    [No Abstract] [Full Text] [Related]

  • 2. Controversy in neurology: the Canadian study on TIA and aspirin. A critique of the Canadian TIA study.
    Kurtzke JF.
    Ann Neurol; 1979 Jun; 5(6):597-9. PubMed ID: 382978
    [No Abstract] [Full Text] [Related]

  • 3. Controversy in the interpretation of clinical trials.
    Armitage P.
    Ann Neurol; 1979 Jun; 5(6):601-2. PubMed ID: 382980
    [No Abstract] [Full Text] [Related]

  • 4. Summary of design features: clinical trials of platelet-active drugs in cerebrovascular disease.
    Friedman LM.
    Circulation; 1980 Dec; 62(6 Pt 2):V88-9. PubMed ID: 7002355
    [Abstract] [Full Text] [Related]

  • 5. A randomized trial of aspirin and sulfinpyrazone in patients with threatened stroke. Results and methodologic issues.
    Gent M, Barnett HJ, Sackett DL, Taylor DW.
    Circulation; 1980 Dec; 62(6 Pt 2):V97-105. PubMed ID: 7002357
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A randomized trial of aspirin and sulfinpyrazone in patients with TIA.
    Candelise L, Landi G, Perrone P, Bracchi M, Brambilla G.
    Stroke; 1982 Dec; 13(2):175-9. PubMed ID: 7039004
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The Canadian trial of aspirin and sulfinpyrazone in threatened stroke.
    Whisnant JP.
    Am Heart J; 1980 Jan; 99(1):129-30. PubMed ID: 6985763
    [No Abstract] [Full Text] [Related]

  • 14. Controlled trial of aspirin in cerebral ischemia (AITIA study).
    Fields WS, Lemak NA, Frankowski RF, Hardy RJ.
    Thromb Haemost; 1979 Feb 28; 41(1):135-41. PubMed ID: 384582
    [No Abstract] [Full Text] [Related]

  • 15. A randomized trial of aspirin and sulfinpyrazone in threatened stroke.
    Canadian Cooperative Study Group.
    N Engl J Med; 1978 Jul 13; 299(2):53-9. PubMed ID: 351394
    [Abstract] [Full Text] [Related]

  • 16. [TIA... An aspirin?].
    van 't Veer WJ.
    Ned Tijdschr Geneeskd; 1996 Mar 16; 140(11):631-2. PubMed ID: 8649536
    [No Abstract] [Full Text] [Related]

  • 17. Does platelet antiaggregant therapy lessen the severity of stroke?
    Grotta JC, Lemak NA, Gary H, Fields WS, Vital D.
    Neurology; 1985 May 16; 35(5):632-6. PubMed ID: 3887210
    [Abstract] [Full Text] [Related]

  • 18. Does aspirin prevent stroke?
    Mitchell JR.
    Practitioner; 1979 Nov 16; 223(1337):668-72. PubMed ID: 394138
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Placebo-controlled, double-blind clinical trials can impede medical progress.
    Ritter JM.
    Lancet; 1980 May 24; 1(8178):1126-7. PubMed ID: 6103452
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.